Cargando…

Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space

#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a

Detalles Bibliográficos
Autores principales:	Orfanos, Sarah, El Husseini, Ibrahim, Nahass, Thomas, Radbel, Jared, Hussain, Sabiha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533378/ https://www.ncbi.nlm.nih.gov/pubmed/33043052 http://dx.doi.org/10.1183/23120541.00455-2020

Ejemplares similares

Tissue Plasminogen Activator in Critically Ill Adults with COVID-19
por: Douin, David J., et al.
Publicado: (2021)

Physiological dead space and alveolar ventilation in ventilated infants
por: Williams, Emma, et al.
Publicado: (2021)

Whole lung lavage decreases physiological dead space in patients with pulmonary alveolar proteinosis: two case reports
por: Fujihara, Tatsuya, et al.
Publicado: (2023)

Correction to: Physiological dead space and alveolar ventilation in ventilated infants
por: Williams, Emma, et al.
Publicado: (2021)

Causes of a high physiological dead space in critically ill patients
por: Wagner, Peter D
Publicado: (2008)

High incidence of decreased cortisol reserve in brain-dead potential organ-donors
por: Dimopoulou, I, et al.
Publicado: (2002)

Physiologic Improvement in Respiratory Acidosis Using Extracorporeal Co(2) Removal With Hemolung Respiratory Assist System in the Management of Severe Respiratory Failure From Coronavirus Disease 2019
por: Akkanti, Bindu, et al.
Publicado: (2021)

The Volume of the Dead Space in Breathing
Publicado: (1921)

Increased physiological dead space at exercise is a marker of mild pulmonary or cardiovascular disease in dyspneic subjects
por: Plantier, Laurent, et al.
Publicado: (2018)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011)

Nasal high flow reduces dead space
por: Möller, Winfried, et al.
Publicado: (2017)

Microcirculatory dysfunction and dead-space ventilation in early ARDS: a hypothesis-generating observational study
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

Telephone-based anticoagulation management in the homebound setting: a retrospective observational study
por: Hassan, Samer, et al.
Publicado: (2013)

The Plasminogen–Activator Plasmin System in Physiological and Pathophysiological Angiogenesis
por: Ismail, Asmaa Anwar, et al.
Publicado: (2021)

Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction
por: Raczyńska, Dorota, et al.
Publicado: (2015)

Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13
por: Fan, Mengchen, et al.
Publicado: (2016)

Assessment of dead-space ventilation in patients with acute respiratory distress syndrome: a prospective observational study
por: Doorduin, Jonne, et al.
Publicado: (2016)

Physiological dead space ventilation, disease severity and outcome in ventilated patients with hypoxaemic respiratory failure due to coronavirus disease 2019
por: Vasques, Francesco, et al.
Publicado: (2020)

Resting Physiologic Dead Space as Predictor of Postoperative Pulmonary Complications After Robotic-Assisted Lung Resection: A Pilot Study
por: Godbole, Rohit, et al.
Publicado: (2022)

Physiologic dead space is independently associated with mortality and discharge of mechanically ventilated patients with COVID-19 ARDS: a retrospective study
por: Mollura, Maximiliano, et al.
Publicado: (2023)

Long-term stability of recombinant tissue plasminogen activator at -80 C
por: Shaw, George J, et al.
Publicado: (2009)

Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
por: Yang, Hung-Wei, et al.
Publicado: (2012)

Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
por: Bäumer, Wolfgang, et al.
Publicado: (2013)

Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
por: Dybowska, Małgorzata, et al.
Publicado: (2020)

Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage
por: Teekaput, Chutithep, et al.
Publicado: (2022)

Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report
por: Radbel, Jared, et al.
Publicado: (2020)

Aspiration of airway dead space (ASPIDS) in mechanically ventilated patients
por: Robertis, E De, et al.
Publicado: (1998)

Sarcoid-Like Granulomatous Disease: Pathologic Case Series in World Trade Center Dust Exposed Rescue and Recovery Workers
por: Sunil, Vasanthi R., et al.
Publicado: (2019)

Physiologic Factors Influencing the Arterial-To-End-Tidal CO(2) Difference and the Alveolar Dead Space Fraction in Spontaneously Breathing Anesthetised Horses
por: Mosing, Martina, et al.
Publicado: (2018)

First Direct Observation of the Dead-Cone Effect
por: Zardoshti, Nima
Publicado: (2020)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

A Neonatal Thrombosis Patient Treated Successfully with Recombinant Tissue Plasminogen Activator
por: Erdinç, Kemal, et al.
Publicado: (2013)

Stability of Recombinant Tissue Plasminogen Activator at −30 °C Over One Year
por: Alkatheri, Abdulmalik
Publicado: (2012)

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator
por: Ong, Cheung-Ter, et al.
Publicado: (2017)

Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
por: Essig, Fabian, et al.
Publicado: (2021)

The Use of Low-Dose Recombinant Tissue Plasminogen Activator to Treat a Preterm Infant with an Intrauterine Spontaneous Arterial Thromboembolism
por: Demirelli, Yaşar, et al.
Publicado: (2015)

Brain Dead and Pregnant
por: Moguillansky, Natalia, et al.
Publicado: (2023)

Options for reducing HIV transmission related to the dead space in needles and syringes
por: Zule, William A., et al.
Publicado: (2018)

‘Other Spaces’ for the Dangerous Dead of Provincial England, c.1752–1832
por: HURREN, ELIZABETH T.
Publicado: (2018)

Quantification of COVID-19 Vaccine Needle and Syringe Dead Space Volumes
por: Smith, Derek M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nfsmn8mi4a26qdhnb402egl1vq